Early use (&lt;5 days of hospitalization) of interferon-alpha 2b in very severe patients with #COVID19 is associated with lower mortality than no administration. Late use has the opposite effect. In moderate patients it is not effective. https://t.co/HuH0swOHaz https://t.co/Q6sJA72KYW